Myopia Control: The Growing Epidemic and Modern Solutions

## A Global Vision Crisis Myopia, commonly known as nearsightedness, is no longer just a minor inconvenience corrected by glasses. It has become a global public health concern. Current projections estimate that by 2050, nearly half of the world's population will be myopic, with approximately 10 percent experiencing high myopia. In the United States, myopia prevalence among children has nearly doubled over the past three decades, and the COVID-19 pandemic accelerated this trend as children spent unprecedented amounts of time on screens and indoors. Why does this matter beyond the need for corrective lenses? High myopia (prescriptions above -6.00 diopters) significantly increases the risk of sight-threatening conditions later in life, including retinal detachment, glaucoma, cataracts, and myopic macular degeneration. Every additional diopter of myopia increases these risks, which is why slowing myopia progression in children is not just about reducing prescription strength but about protecting lifelong eye health. ## Why Is Myopia Increasing? The myopia epidemic is driven by a combination of genetic and environmental factors. While genetics play a role (children with two myopic parents have a significantly higher risk), the rapid increase in prevalence points to environmental causes. **Increased near work.** Children today spend far more time on close-up tasks like reading, homework, and screen use than previous generations. Extended near work signals the eye to elongate, which is the physical mechanism behind myopia development. **Reduced outdoor time.** Research consistently shows that outdoor time is protective against myopia. Children who spend at least two hours per day outdoors have significantly lower rates of myopia onset. The mechanism is thought to involve the intensity and spectrum of natural sunlight, which may regulate eye growth. Modern children spend an average of only 45 minutes per day outdoors. **Earlier onset.** Children are developing myopia at younger ages, which means more years of potential progression and higher ultimate prescriptions. A child who becomes myopic at age 6 will typically end up with a much higher prescription than one who develops myopia at age 12. ## Modern Myopia Management Options The most important message for parents is that myopia progression can be slowed. We are no longer limited to simply prescribing stronger glasses each year. Several evidence-based treatments have demonstrated the ability to reduce myopia progression by 50 percent or more. **Orthokeratology (Ortho-K).** Ortho-K involves wearing specially designed rigid gas-permeable contact lenses overnight. These lenses gently reshape the cornea while the child sleeps, providing clear vision during the day without glasses or contacts. Beyond the convenience factor, ortho-K has been shown to slow axial elongation of the eye, which is the fundamental driver of myopia progression. Studies demonstrate a 40 to 60 percent reduction in myopia progression with consistent ortho-K wear. **Low-dose atropine drops.** Atropine eye drops in concentrations of 0.01 to 0.05 percent have emerged as one of the most effective myopia control treatments. Applied once daily at bedtime, these drops slow eye elongation with minimal side effects at low concentrations. The LAMP study and subsequent research have shown that low-dose atropine can reduce myopia progression by 50 to 60 percent. Your eye doctor can prescribe these from a compounding pharmacy. **MiSight soft contact lenses.** MiSight 1 day lenses by CooperVision are the first and only FDA-approved soft contact lens specifically designed for myopia control in children ages 8 to 12. These daily disposable lenses use a dual-focus design that provides clear vision while simultaneously creating a signal that slows eye growth. Clinical trials showed a 59 percent reduction in myopia progression over three years. **Specialized spectacle lenses.** Several new spectacle lens designs incorporate peripheral defocus technology to slow myopia progression. Essilor's Stellest lenses and Hoya's MiyoSmart lenses have shown promising results in clinical trials, offering a non-contact-lens option for younger children or those who prefer glasses. These lenses look like normal glasses but incorporate microscopic lenslets that create the myopic defocus signal needed to slow eye growth. ## The Role of Lifestyle Changes While optical and pharmaceutical treatments are the most effective interventions, lifestyle modifications provide additional benefit and should be part of every myopia management plan. - **Increase outdoor time** to a minimum of two hours per day. This is the single most impactful lifestyle change for myopia prevention and control - **Follow the 20-20-20 rule** during near work and screen time - **Maintain proper reading distance** of at least 14 to 16 inches - **Ensure adequate lighting** during close-up tasks - **Limit continuous screen time** to 30-minute intervals with breaks ## When to Start Treatment Early intervention is critical. If your child is diagnosed with myopia, or if myopia runs in your family, consult an optometrist who specializes in myopia management as soon as possible. The earlier treatment begins, the greater the cumulative benefit. A child who starts myopia management at age 7 will have a significantly lower final prescription than one who starts at age 12. Many pediatric eye care providers recommend baseline eye exams at age 6 months, age 3, and before starting school, with annual exams thereafter. If your child squints, holds books or devices close to their face, or complains of blurry distance vision, schedule an exam promptly. ## The Bottom Line Myopia is not inevitable, and high myopia is not an acceptable outcome. With the treatments available in 2026, we can meaningfully slow myopia progression in most children, reducing their lifetime risk of vision-threatening complications. Talk to your eye care provider about which myopia management approach is right for your child.